EcoDrugPlus

Sphingosine Kinase 2

Ensembl ID : ENSMMDG00005007333
Gene Symbol: SPHK2
2 Cross references
200 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSMMDG00005012864
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSMMDG00005015877
Gene Symbol: SYK
1 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSMMDG00005024584
Gene Symbol: LOC115372466
3 Cross references
210 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSMMDG00005002816
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSMMDG00005013458
Gene Symbol: TACR1
3 Cross references
197 Possible Orthologues:

Tachykinin Receptor 1b

Ensembl ID : ENSMMDG00005005618
Gene Symbol: TACR1B
1 Cross references
193 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSMMDG00005024822
Gene Symbol: TACR2
1 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSMMDG00005000329
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSMMDG00005010651
Gene Symbol: TACR3L
1 Cross references
218 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSMMDG00005005595
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSMMDG00005010331
Gene Symbol: TBXAS1
3 Cross references
217 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).